Eanna Fennell
Overview
Explore the profile of Eanna Fennell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nayar S, Turner J, Asam S, Fennell E, Pugh M, Colafrancesco S, et al.
Nat Commun
. 2025 Jan;
16(1):5.
PMID: 39747819
Tertiary lymphoid structures play important roles in autoimmune and non-autoimmune conditions. While many of the molecular mechanisms involved in tertiary lymphoid structure formation have been identified, the cellular sources and...
2.
Masand N, Perry T, Pugh M, Fennell E, Hennessy A, Wei W, et al.
Haematologica
. 2024 Sep;
110(1):193-199.
PMID: 39219456
No abstract available.
3.
Gunawardana J, Law S, Sabdia M, Fennell E, Hennessy A, Leahy C, et al.
Am J Hematol
. 2024 Aug;
99(11):2096-2107.
PMID: 39152767
In classical Hodgkin lymphoma (cHL), responsiveness to immune-checkpoint blockade (ICB) is associated with specific tumor microenvironment (TME) and peripheral blood features. The role of ICB in nodular lymphocyte predominant Hodgkin...
4.
Majumder S, Santacroce G, Maeda Y, Zammarchi I, Puga-Tejada M, Ditonno I, et al.
Gut
. 2024 Aug;
73(10):1603-1606.
PMID: 39107087
No abstract available.
5.
Siciliano M, Bertolazzi G, Morello G, Tornambe S, Del Corvo M, Granai M, et al.
Blood Adv
. 2024 Jun;
8(16):4330-4343.
PMID: 38861355
Burkitt lymphoma (BL) is characterized by a tumor microenvironment (TME) in which macrophages represent the main component, determining a distinct histological appearance known as "starry sky" pattern. However, in some...
6.
Davies N, Francis T, Oldreive C, Azam M, Wilson J, Byrd P, et al.
Haematologica
. 2024 Jun;
109(12):3989-4006.
PMID: 38841800
Diffuse large B-cell lymphoma (DLBCL) is the most common malignancy that develops in patients with ataxia-telangiectasia, a cancer-predisposing inherited syndrome characterized by inactivating germline ATM mutations. ATM is also frequently...
7.
Perry T, Masand N, Vrzalikova K, Pugh M, Wei W, Hollows R, et al.
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339325
Background: A total of 30-40% of diffuse large B cell lymphoma (DLBCL) patients will either not respond to the standard therapy or their disease will recur. The first-line treatment for...
8.
Pearce H, Croft W, Nicol S, Margielewska-Davies S, Powell R, Cornall R, et al.
Cancer Immunol Res
. 2023 Jan;
11(4):435-449.
PMID: 36689623
Pancreatic ductal adenocarcinoma (PDAC) has a poor clinical outlook. Responses to immune checkpoint blockade are suboptimal and a much more detailed understanding of the tumor immune microenvironment is needed if...
9.
Nohtani M, Vrzalikova K, Ibrahim M, Powell J, Fennell E, Morgan S, et al.
Cancers (Basel)
. 2022 Sep;
14(17).
PMID: 36077832
In this study, we have re-evaluated how EBV status influences clinical outcome. To accomplish this, we performed a literature review of all studies that have reported the effect of EBV...
10.
Syrimi E, Fennell E, Richter A, Vrljicak P, Stark R, Ott S, et al.
iScience
. 2021 Oct;
24(11):103215.
PMID: 34632327
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening disease occurring several weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Deep immune profiling showed acute MIS-C patients had...